1. Home
  2. Analysis
  3. Inbrija
  4. Asa

Inbrija and Asa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Inbrija (levodopa) and Asa (aspirin). Common drug interactions include death among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Inbrija and Asa. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Inbrija?

Inbrija has active ingredients of levodopa. eHealthMe is studying from 7,848 Inbrija users. Check the latest studies of Inbrija.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.

On Jul, 28, 2026

11 people who take Inbrija and Asa together, and have interactions are studied.

Inbrija and Asa drug interactions.

What are the common drug interactions of Inbrija and Asa, by gender? *:

female:

  1. Death

male:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. General physical condition
  4. Muscle disorder (muscle disease)
  5. Oral candidiasis (fungal infection of mouth)
  6. Salivary hypersecretion (excess saliva secretion)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Urinary tract infection
  9. Aphasia (damage to the parts of the brain that control language)
  10. Chest discomfort

What are the common drug interactions of Inbrija and Asa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Burning sensation
  2. Chest pain
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Chest discomfort
  6. Adverse event

What are the existing conditions these people have? *

  1. Parkinson's Disease: 11 people, 100.00%
  2. On And Off Phenomenon: 8 people, 72.73%
  3. Urinary Tract Infection: 1 person, 9.09%
  4. Salivary Hypersecretion (excess saliva secretion): 1 person, 9.09%
  5. Hallucinations (sensations that appear real but are created by your mind): 1 person, 9.09%
  6. Delusion (a false belief or opinion): 1 person, 9.09%
  7. Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Inbrija and Asa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Inbrija and Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Inbrija:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Inbrija and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on levodopa and aspirin (the active ingredients of Inbrija and Asa, respectively), and Inbrija and Asa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.